Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New combo therapy shows promise for inoperable liver cancer
Disease control CompletedThis study tested a new combination treatment for people with liver cancer that cannot be removed by surgery. The treatment involved infusing chemotherapy directly into the liver, followed by a procedure to block the tumor's blood supply, plus two oral and intravenous drugs. The …
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New chemo cocktail shows promise for tough throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) followed by standard radiation and chemo in 60 people with advanced nasopharyngeal cancer, a type of throat cancer common in southern China. The goal was to see if this approac…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 11, 2026 20:51 UTC